Get the Stockscreener App
289.07
0.35%
1.01
After Hours:
289.00
-0.07
-0.02%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $289.07, with a volume of 1.67M.
It is up +0.35% in the last 24 hours and up +6.57% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
See More
Previous Close:
$288.06
Open:
$290.39
24h Volume:
1.67M
Relative Volume:
0.98
Market Cap:
$76.47B
Revenue:
$278.13B
Net Income/Loss:
$6.74B
P/E Ratio:
12.25
EPS:
23.6047
Net Cash Flow:
$7.66B
1W Performance:
+3.48%
1M Performance:
+6.57%
6M Performance:
+7.86%
1Y Performance:
-13.31%
1-Day Range:
$287.00
$293.00
1-Week Range:
$274.01
$293.00
52-Week Range:
$239.51
$338.89
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
289.07 | 76.20B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
384.44 | 345.08B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
92.22 | 115.54B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
381.75 | 82.10B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
274.26 | 33.01B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Built with America: The Cigna Group’s 230-year history of innovation in service of customers - The Cigna Group Newsroom
Cigna Ordered to Face Trial Over $6 Million in Covid Test Costs - news.bloombergtax.com
Here's what the CEOs at major for-profit payers earned last year - Fierce Healthcare
Cigna Group stock (US1255231003): Health insurer reports solid Q1 2026 results and raises full?year - AD HOC NEWS
A Look At Cigna Group (CI) Valuation After Q1 Beat And ACA Plan Exit Announcement - simplywall.st
Cigna Group stock (US1255231003): Health insurer reports Q1 2026 results with modest growth and marg - AD HOC NEWS
Earnings call transcript: Cigna Q1 2026 beats expectations, raises EPS guidance - Investing.com Australia
Cigna Group stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
The Cigna Group (CI)Davis Advisors Dramatically Expands Healthcare Position Amid Sector Rotation in Q1 2026Real-time Trade Ideas - newser.com
Cigna Group's (NYSE:CI) Solid Earnings Are Supported By Other Strong Factors - Yahoo Finance
The Cigna Group (CI) Price Target Boosted by $7 Following Better-than-Expected Q1 - Insider Monkey
Number of shareholders of Cigna Group – GETTEX:CGN - TradingView
Insurers caution shareholders about bad PR, AI risks, tariffs - Modern Healthcare
How Cigna’s Q1 Beat, Higher Guidance and Dividend Move Will Impact Cigna Group (CI) Investors - simplywall.st
Cigna Group stock outperforms competitors despite losses on the day - MarketWatch
Truist Financial Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $350 - 富途牛牛
Bernstein Adjusts Price Target on Cigna to $371 From $358, Maintains Outperform Rating - marketscreener.com
Bernstein raises Cigna stock price target to $371 on strong results - Investing.com India
CIGNA (CI) PT Raised to $371 at Bernstein SocGen Group - StreetInsider
Goldman Sachs Maintains Cigna Group(CI.US) With Buy Rating, Raises Target Price to $340 - Moomoo
Cigna Group stock underperforms Monday when compared to competitors - MarketWatch
Cigna Stock Falls on ACA Exit News Despite Strong Q1 Earnings BeatNews and Statistics - IndexBox
Cigna Reports Q1 Gains, Announces ACA Marketplace Exit - HEALTH CARE un-covered
Goldman Sachs Adjusts Cigna Group Price Target to $340 From $335, Maintains Buy Rating - marketscreener.com
The The Cigna Group (NYSE:CI) First-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Guggenheim raises Cigna stock price target on strong quarterly results - Investing.com
Semafor World Economy Summit: David Cordani shares lessons from nearly two decades leading The Cigna Group - The Cigna Group Newsroom
TD Cowen Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $338 - 富途牛牛
What Does Representative Moskowitz's Cigna Sale Signal - Kavout
Why Cigna (CI) Shares Are Trading Lower Today - Yahoo Finance Australia
PFA Pension Forsikringsaktieselskab Acquires Shares of 189,982 Cigna Group $CI - MarketBeat
Is Cigna Stock Worth Watching Right Now - Kalkine Media
Is It Time To Reassess Cigna (CI) After A 13.7% One Year Share Price Decline - simplywall.st
Cigna Group (NYSE:CI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Cigna appoints Brian Evanko as next CEO - MSN
Analysts Have Made A Financial Statement On The Cigna Group's (NYSE:CI) First-Quarter Report - Moomoo
Oppenheimer Asset Management Inc. Buys 4,704 Shares of Cigna Group $CI - MarketBeat
Cigna Group Raises Full Year Forecast After Strong First Quarter - HarianBasis.co
Davis Selected Advisers Purchases 96,534 Shares of Cigna Group $CI - MarketBeat
Cigna Refocuses On Evernorth And AI As eviCore Review Advances - simplywall.st
Cigna’s exit adds to ObamaCare marketplace upheaval - AOL.com
Cigna’s exit adds to Obamacare marketplace upheaval - MSN
Cigna Pulls Out of Obamacare - WBLS
Cigna pulls out of the ACA, Aidoc raises $150M, the White House swaps out Surgeon General nominee - VatorNews
Royal Bank Of Canada Forecasts Strong Price Appreciation for Cigna Group (NYSE:CI) Stock - MarketBeat
UConn Health Reaches New Multi-Year Agreement with Cigna Ensuring Continued Access to Care - UConn Today
UConn Health reaches new multiyear agreement with Cigna - Hartford Business Journal
INVESCO Global Core Equity Fund's The Cigna Group(CI) Holding History - GuruFocus
Cigna exits ACA marketplace, affecting 369,000 members - qz.com
Cigna Q1 Earnings Support A Higher Valuation (NYSE:CI) - Seeking Alpha
Cigna Group (CI) Q1 2026 Earnings Call Transcript - The Motley Fool
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):